Finder Energy nears FID for Kuda Tasi/Jahal; EIS/FDP lodged, debt financing underway as oil prices rise, targeting first oil ...

NoviqTech subsidiary Coralia launches GBR biochar trial to convert invasive Chinese apple trees into biochar for long-term ...

Recce inks 10-year exclusive MENA licensing deal for R327G diabetic foot gel; upfront fees up to $5m, 30% net sales, Phase ...

Cauldron Energy (ASX: CXU) has announced that an initial conceptual JORC 2012 Exploration Target of 9.4-42.7 Mlbs U3O8 has ...

KMD Brands lifts portfolio as Next Level strategy boosts Rip Curl, Kathmandu; margins rise despite Oboz softness; stronger ...

Barton Gold delivers high-grade Phase 2 assays at Tunkillia Area 51, signaling resource growth and longer mine life ahead of ...

Tivan hits highly anomalous copper-gold in Turiscai stream sampling, boosting porphyry targets ahead of maiden drilling in ...

Minbos Resources advances Cabinda with US$4.8m drawdown of a US$16m IDC facility; Phase 1 finished and project now fully ...

EMVision de-risks rural stroke use with aeromedical feasibility study; First Responder Brain Scanner unaffected by flight, ...

Sovereign finds monazite and heavy REEs across Kasiya pits, with high Dy-Tb and Y; monazite by-product could add revenue with ...

Aroa Biosurgery beats FY26 guidance as Myriad drives revenue 23% YoY; FY27 targets NZ$115-125m, Symphony catalyst; cash-rich, ...

NeuroScientific reports on StemSmart Crohn’s trial: 80% clinical response in five patients; safe, paving Phase 2 and a ...